首页> 外文期刊>American Journal of Ophthalmology: The International Journal of Ophthalmology >The maximal tolerable reduction in hyperopic correction in patients with refractive accommodative esotropia: a 6-month follow-up study.
【24h】

The maximal tolerable reduction in hyperopic correction in patients with refractive accommodative esotropia: a 6-month follow-up study.

机译:屈光调节性内斜视患者远视矫正的最大可耐受减少:6个月的随访研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To investigate the optimal amount of safe under-correction in patients with refractive accommodative esotropia. DESIGN: Prospective noncomparative interventional case series. METHODS: Patients with refractive accommodative esotropia wore trial glasses based on cycloplegic refraction, then -0.25 diopters (D) of minus sphere lenses were placed on both lenses of the trial glasses and the deviation was measured. Minus spheres of -0.25 D were continuously added until the angle of deviation increased; the minus spheres added just before the deviation increase were defined as the maximal tolerable amount of under-correction. A total of 38 patients were prescribed under-corrected spectacles up to -1.5 D and followed for 6 months. RESULTS: Thirty-one patients underwent the maximal tolerable amount of under-correction and 7 underwent -1.5 D of under-correction. A mean -0.89 D of under-correction was performed. We observed no deterioration in visual acuity, stereoacuity, or fusional ability during the follow-up period in any of the patients. Small increase in the angle of deviation of 2 prism diopters was noted in 2 patients. The mean spherical equivalent refractive error of both eyes (P = .012) and age of onset (P = .006) showed strong positive correlations with the maximal tolerable amount of under-correction. CONCLUSIONS: A reduction in hyperopic correction by the maximal tolerable amount of under-correction was performed without notable short-term side effects. The spherical equivalent refractive error and age of onset appear to be useful clinical indices in determining the appropriate amount of under-correction.
机译:目的:探讨屈光调节性内斜视患者的安全矫正的最佳量。设计:前瞻性非比较性介入病例系列。方法:患有屈光性调节性内斜视的患者戴有基于睫状肌麻痹性屈光度的试验眼镜,然后将-0.25屈光度(D)的负球镜戴在该试验眼镜的两个镜片上,并测量偏差。连续添加-0.25 D的负球,直到偏差角度增加为止。恰好在偏差增加之前添加的负球定义为校正不足的最大容许量。共有38例患者接受了至-1.5 D的未矫正眼镜处方,并随访了6个月。结果:31例患者接受了最大容许的矫正不足,7例患者接受了-1.5 D的矫正不足。进行平均-0.89 D的校正不足。我们在任何患者的随访期间均未观察到视力,立体视力或融合能力的恶化。 2例患者中2棱镜屈光度的偏离角略有增加。两只眼睛的平均球体等效屈光不正(P = 0.012)和发病年龄(P = 0.006)与最大的矫正不足量呈正相关。结论:最大耐受​​量的矫正减少了远视矫正,但没有明显的短期副作用。球形等效屈光不正和发病年龄似乎是确定适当矫正量的有用的临床指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号